Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 0.51.

  • Maravai Lifesciences Holdings' Equity Ratio rose 609.79% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 609.79%. This contributed to the annual value of 0.57 for FY2024, which is 780.69% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Equity Ratio of 0.51 as of Q3 2025, which was up 609.79% from 0.52 recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Equity Ratio high stood at 0.57 for Q4 2024, and its period low was 0.16 during Q1 2021.
  • Its 5-year average for Equity Ratio is 0.41, with a median of 0.4 in 2023.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Equity Ratio skyrocketed by 13344.98% in 2021 and then plummeted by 248.87% in 2025.
  • Maravai Lifesciences Holdings' Equity Ratio (Quarter) stood at 0.28 in 2021, then surged by 39.51% to 0.4 in 2022, then skyrocketed by 33.88% to 0.53 in 2023, then grew by 7.81% to 0.57 in 2024, then decreased by 11.17% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q3 2025, 0.52 for Q2 2025, and 0.55 during Q1 2025.